Eye lens doses in nuclear medicine: a multicentric study in Belgium and Poland

Research output: Contribution to journalArticlepeer-review


Institutes & Expert groups

  • IFJ–PAN - The Henryk Niewodniczanski - Institute of Nuclear Physics
  • Maria Skłodowska-Curie Institute of Oncology

Documents & links



This study aimed to investigate the level of the eye lens (EL) doses in nuclear medicine in the light of the new International Commission on Radiological Protection limit. In 7 Belgian and 1 Polish hospitals, 45 staff members were monitored for EL (Hp(3)) and whole-body (WB) (Hp(10)) doses using dedicated dosemeters. Weekly measurements were carried out and used to estimate annual doses. Mostly diagnostic procedures involving radionuclides such as 99mTc and 18F were monitored; measurements were also performed for therapeutic procedures. The cumulative doses showed important variation across the participants. The weekly EL and WB doses ranged from 0.02 to 0.27 and 0.03 to 0.17 mSv, respectively; the annual EL and WB doses ranged from 0.6 to 9.3 and 0.9 to 8.0 mSv, respectively. Some correlation was found between the EL and theWB doses. No significant correlation with the manipulated activities was found.


Original languageEnglish
Pages (from-to)297–301
JournalRadiation protection dosimetry
Issue number1-4
Publication statusPublished - 1 Sep 2016


  • eye lens, nuclear medicine, Eye lens dose

ID: 1565514